BTIG on Jade Biosciences (JBIO): 'We See Sentiment Continuing to Rise for APRIL Inhibitors in IgAN' Mar 6, 2026 12:59PM
Jade Biosciences (JBIO) PT Raised to $40 at Stifel: "We like the setup for JADE101" Mar 6, 2026 12:16PM
LifeSci Capital Starts Jade Biosciences (JBIO) at Outperform Mar 6, 2026 08:30AM
H.C. Wainwright Starts Jade Biosciences (JBIO) at Buy Jan 7, 2026 06:48AM
Jade Biosciences outlines 2026 clinical milestones for autoimmune drugs Jan 5, 2026 07:00AM


Dec 22, 2025 04:41PM Jade Biosciences (JBIO) files for 3.21M share offering by selling stockholders
Nov 24, 2025 04:28PM Clear Street Starts Jade Biosciences (JBIO) at Buy
Nov 14, 2025 04:17PM Jade Biosciences (JBIO) files for 16.13M share offering by selling stockholders
Nov 13, 2025 07:01PM Jade Biosciences (JBIO) Misses Q3 EPS by 48c
Nov 10, 2025 02:33AM Jade Biosciences presents safety data for JADE101 at nephrology conference
Oct 17, 2025 04:05PM Jade Biosciences to present JADE101 data at kidney conference
Oct 9, 2025 06:06AM BTIG Starts Jade Biosciences (JBIO) at Buy
Oct 7, 2025 07:05AM Jade Biosciences unveils JADE201 antibody for autoimmune diseases
Aug 13, 2025 05:15PM Jade Biosciences, Inc. (JBIO) Misses Q2 EPS by 55c
Jul 14, 2025 06:36AM Jefferies Starts Jade Biosciences (JBIO) at Buy
Jul 1, 2025 07:01AM Jade Biosciences (JBIO) Appoints Brad Dahms as Chief Financial Officer
Jun 16, 2025 01:35AM Guggenheim Upgrades Jade Biosciences (JBIO) to Buy
May 5, 2025 01:01AM Stifel Starts Jade Biosciences (JBIO) at Buy
May 2, 2025 05:30AM TD Cowen Starts Jade Biosciences (JBIO) at Buy